TCL Archive Historical Vs. Current Controls: Comparability, Ethical Issues Argued By Moertel, Freireich April 20, 1979
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive FDA Didn’t Tell Advisors About Data Linking Obesity Drug With Precancerous Lesions. June 2, 2006
